CIA
KRON

Choate Investment Advisors’s Kronos Bio KRON Stock Holding History

Choate Investment Advisors’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-274,787
Closed -$261K – 410
2024
Q4 		$261K Sell
274,787
-33,910
-11% -$32K 0.01% 349
2024
Q3 		$309K Hold
308,697
– – 0.01% 308
2024
Q2 		$383K Hold
308,697
– – 0.01% 279
2024
Q1 		$401K Hold
308,697
– – 0.01% 291
2023
Q4 		$386K Hold
308,697
– – 0.01% 274
2023
Q3 		$401K Hold
308,697
– – 0.02% 266
2023
Q2 		$531K Hold
308,697
– – 0.02% 201
2023
Q1 		$451K Hold
308,697
– – 0.02% 194
2022
Q4 		$500K Hold
308,697
– – 0.03% 182
2022
Q3 		$1.03M Hold
308,697
– – 0.07% 109
2022
Q2 		$1.12M Hold
308,697
– – 0.07% 110
2022
Q1 		$2.23M Buy
308,697
+26,903
+10% +$229K 0.12% 80
2021
Q4 		$3.83M Sell
281,794
-111,642
-28% -$1.75M 0.22% 45
2021
Q3 		$8.25M Buy
393,436
+36,712
+10% +$789K 0.53% 21
2021
Q2 		$8.54M Buy
+356,724
New +$9.03M 0.52% 21

Other funds holding KRON

VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.65B AUM 16.42% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Choate Investment Advisors's KRON Position: Q1 2025 in Review

Choate Investment Advisors sold out of Kronos Bio (KRON) in Q1 2025, closing a stake of 274,787 shares — an estimated $261K sold.

Choate Investment Advisors first reported a position in KRON in Q2 2021 and held it in 15 quarters. The position peaked at $8.54M in Q2 2021. 47 funds tracked by Wall St. Rank hold KRON as of Q1 2025.

  • Choate Investment Advisors reported no remaining Kronos Bio position as of Q1 2025 after selling out during the quarter.
  • Choate Investment Advisors sold 274,787 Kronos Bio shares in Q1 2025, an estimated $261K.
  • Choate Investment Advisors first reported a position in Kronos Bio in Q2 2021 and held it in 15 quarters.
  • Choate Investment Advisors's Kronos Bio position peaked at $8.54M in Q2 2021.
  • 47 funds tracked by Wall St. Rank held Kronos Bio as of Q1 2025.

Based on Choate Investment Advisors's 13F filing for Q1 2025, filed 14 May 2025.